Albert David Share Price

Albert David Share Price

  • 834.9010.90 (1.33%)
  • Live
  • As On: 04 Mar, 2025, 11:34 AM IST
Loading...
Open826.95
High842.25
Low810.10
Prev Close824.00
Volume3,763
VWAP(₹)827.59

Albert David share price insights

  • New 52 Week Low

    Stock touched a new 52 week low today.
  • Contingent Liabilities Coverage

    Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)
  • PAT: Slipping to Red

    Company has posted a loss of Rs 9.39 cr in Dec 31, 2024 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)
  • Stock Returns vs Nifty Smallcap 100

    Stock gave a 3 year return of 57.72% as compared to Nifty Smallcap 100 which gave a return of 48.06%. (as of last trading session)
  • Albert David Share Price Update

    Albert David Ltd. share price moved up by 1.33% from its previous close of Rs 824.00. Albert David Ltd. stock last traded price is 834.90

    Share PriceValue
    Today/Current/Last834.90
    Previous Day824.00

Found Insights useful?

Albert David Share Price Returns

1 Day1.33%
1 Month-28.22%
3 Months-39.26%
1 Year-34.23%
3 Years59.8%
5 Years98.57%

Key Metrics

PE Ratio(x)11.78
EPS - TTM(₹)70.86
MCap(₹ Cr.)476.29
MCap Rank85
PB Ratio(x)1.23
Div Yield(%)1.38
Face Value(₹)10.00
52W High(₹)1,753.95
52W Low(₹)810.10
MCap/Sales1.69
Beta(1 Month)0.81
BV/Share(₹)671.05

Albert David Share Recommendations

Recent Recos
  • Target₹570
  • OrganizationIndependent Analyst
  • BUY

Albert David Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Albert David Financials

  • Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Income74.08119.07112.4299.50105.16
    Total Income Growth (%)-37.795.9212.98-5.39-0.10
    Total Expenses84.1193.8890.2681.3281.61
    Total Expenses Growth (%)-10.414.0111.00-0.363.74
    EBIT-10.0325.1922.1618.1823.55
    EBIT Growth (%)-139.8213.7121.85-22.81-11.46
    Profit after Tax (PAT)-9.3918.0718.8412.9118.72
    PAT Growth (%)-151.95-4.1045.94-31.01-7.79
    EBIT Margin (%)-13.5421.1619.7118.2722.40
    Net Profit Margin (%)-12.6715.1816.7612.9817.80
    Basic EPS (₹)-16.4531.6733.0222.6332.80
    FY 2024FY 2023FY 2022FY 2021FY 2020
    Total Revenue420.01356.96329.35264.63327.91
    Total Revenue Growth (%)17.668.3824.46-19.301.31
    Total Expenses322.73306.23282.06237.19298.95
    Total Expenses Growth (%)5.398.5718.92-20.661.40
    Profit after Tax (PAT)75.4236.1735.2622.1419.17
    PAT Growth (%)108.492.6059.2315.52-28.05
    Operating Profit Margin (%)26.9214.9815.2511.359.27
    Net Profit Margin (%)20.8010.5911.248.945.97
    Basic EPS (₹)132.1563.3961.7838.8033.59

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • PAT: Slipping to Red

      Company has posted a loss of Rs 9.39 cr in Dec 31, 2024 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)
    • Quarterly Topline Performance

      Company witnessed QoQ revenue decline of 37.79%, which is lowest in the last 3 years. (Source: Standalone Financials)
  • AnnualFY 2024FY 2023FY 2022FY 2021FY 2020
    Total Assets497.99423.39402.84341.40320.22
    Total Assets Growth (%)17.625.1018.006.618.41
    Total Liabilities115.01111.82123.3797.0297.42
    Total Liabilities Growth (%)2.85-9.3627.16-0.4114.69
    Total Equity382.98311.57279.47244.38222.80
    Total Equity Growth (%)22.9211.4914.369.695.87
    Current Ratio (x)3.753.072.332.772.48
    Total Debt to Equity (x)0.010.010.010.000.01
    Contingent Liabilities5.278.232.814.074.14

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Contingent Liabilities Coverage

      Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)
  • AnnualFY 2024FY 2023FY 2022FY 2021FY 2020
    Net Cash flow from Operating Activities45.5010.5240.3636.6130.09
    Net Cash used in Investing Activities-33.25-5.00-39.70-36.68-20.00
    Net Cash flow from Financing Activities-8.27-6.36-4.88-1.71-10.17
    Net Cash Flow3.99-0.83-4.13-1.770.00
    Closing Cash & Cash Equivalent5.441.45-1.494.646.42
    Closing Cash & Cash Equivalent Growth (%)276.29-197.04-132.08-27.650.07
    Total Debt/ CFO (x)0.050.380.090.010.05

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Cash from Operations vs PAT

      Operating cash flow of Rs 45.5 cr is 0.6 times compared to the reported net profit of Rs 75.42 cr. (Source: Standalone Financials)
    • Increase in Cash from Investing

      Company has used Rs 33.25 cr for investing activities which is an YoY increase of 565.6%. (Source: Standalone Financials)
  • AnnualFY 2024FY 2023FY 2022FY 2021FY 2020
    Return on Equity (%)19.6911.6112.619.068.60
    Return on Capital Employed (%)24.4615.7716.2710.7712.43
    Return on Assets (%)15.148.548.756.485.98
    Interest Coverage Ratio (x)325.13131.04106.4055.6237.37
    Asset Turnover Ratio (x)0.790.830.840.75100.18
    Price to Earnings (x)8.148.088.619.729.59
    Price to Book (x)1.600.941.090.880.82
    EV/EBITDA (x)5.604.535.104.964.76
    EBITDA Margin (%)28.8117.4918.0614.6811.66

    No Data Available

    Insights
    • ROE Outperforming 5 Year Average

      Company delivered ROE of 19.69% in year ending Mar 31, 2024 outperforming its 5 year avg. of 13.06%. (Source: Standalone Financials)

Found Financials useful?

Albert David Technicals

Albert David Peer Comparison

Insights
  • Stock Returns vs Nifty Smallcap 100

    Stock gave a 3 year return of 57.72% as compared to Nifty Smallcap 100 which gave a return of 48.06%. (as of last trading session)
  • Stock Returns vs Nifty Pharma

    Stock generated 57.72% return as compared to Nifty Pharma which gave investors 56.71% return over 3 year time period. (as of last trading session)

Albert David Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters35,45,95862.13 %0.00
    Pledge00.00 %0.00
    FII49,1010.86 %-0.02
    DII92,6501.62 %0.00
    MF8000.01 %0.00
    Others20,19,45335.39 %0.02
  • CategoryDec 2024Sep 2024Jun 2024Mar 2024
    Promoters62.1362.1362.1362.13
    Pledge0.000.000.000.00
    FII0.860.880.800.98
    DII1.621.621.661.66
    Mutual Funds0.010.010.010.01
    Others35.3935.3635.4135.23

Mutual Funds Ownership

No Data Available

Corporate Actions

  • Board Meeting

    Quarterly Results

    Feb 03, 2025

    General Meeting

    -

    Nov 26, 2024

    Board Meeting

    Quarterly Results

    Nov 06, 2024

  • Announced onMeeting on
    Feb 03, 2025Feb 12, 2025
    Quarterly Results
    Nov 06, 2024Nov 14, 2024
    Quarterly Results
    Aug 02, 2024Aug 09, 2024
    Quarterly Results
    May 06, 2024May 13, 2024
    Audited Results & Final Dividend
    Jan 25, 2024Feb 05, 2024
    Quarterly Results
  • Announced onEx-DateDividend%
    May 13, 2024Aug 02, 2024115%
    May 19, 2023Aug 03, 202390%
    May 11, 2022Aug 01, 202290%
    Jun 17, 2021Sep 06, 202160%
    Mar 03, 2020Mar 13, 202070%
  • No Data Available

  • No Data Available

  • Announced onEx-Date
    Mar 12, 1996Feb 05, 1996
    Rights ratio: 2 share for every 3 held at a price of Rs 20.0
    Sep 30, 1993Mar 26, 1993
    Rights ratio: 1 share for every 2 held at a price of Rs 20.0
  • Announced onMeeting on
    Nov 26, 2024Dec 28, 2024
    -
    May 13, 2024Aug 09, 2024
    Book closure from Aug 3, 2024 to Aug 9, 2024
    Nov 15, 2023Dec 18, 2023
    -
    Jul 18, 2023Aug 10, 2023
    A.G.M.
    Jul 05, 2022Aug 09, 2022
    Book closure from Aug 3, 2022 to Aug 9, 2022

About Albert David

Albert David Ltd., incorporated in the year 1938, is a Small Cap company (having a market cap of Rs 470.27 Crore) operating in Pharmaceuticals sector.

Show More

Key Indices Listed On

-

Address

D - Block, 3rd Floor,Gillander House,Netaji Subhas Road,Kolkata, West Bengal - 700001

Executive Leadership

AK

Arun Kumar Kothari

Executive Chairman
UM

Umesh Manohar Kunte

Managing Director & CEO
AV

Anand Vardhan Kothari

Non Executive Director
PD

Prabhawati Devi Kothari

Non Executive Director
Show More

Auditors

L B Jha & Co.
Basu Chanchani & Deb

FAQs about Albert David share

  • 1. What's Albert David share price today and what are Albert David share returns ?
    As of today Albert David share price is up by 1.33% basis the previous closing price of Rs 851.3. Albert David share price is Rs 834.90.
  • 2. What is 52 week high/low of Albert David share price?
    In last 52 weeks Albert David share had a high price of Rs 1,753.95 and low price of Rs 810.10
  • 3. How can I quickly analyze Albert David stock?
    Albert David share can be quickly analyzed on following metrics:
    • Stock's PE is 11.78
    • Price to Book Ratio of 1.23
  • 4. What's the market capitalization of Albert David?
    Albert David share has a market capitalization of Rs 476.29 Cr. Within Pharmaceuticals sector, it's market cap rank is 85.
  • 5. What is the CAGR of Albert David?
    The CAGR of Albert David is 10.01.
  • 6. Who is the Chief Executive Officer of Albert David?
    Umesh Manohar Kunte is the Managing Director & CEO of Albert David
  • 7. What is the PE & PB ratio of Albert David?
    The PE ratio of Albert David stands at 11.63, while the PB ratio is 1.23.
  • 8. Who's the chairman of Albert David?
    Arun Kumar Kothari is the Executive Chairman of Albert David
  • 9. What are the Albert David quarterly results?
    On Standalone basis, Albert David reported a total income and loss of Rs 74.08 Cr and Rs -9.39 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2024-03-31 was Rs 420.01 Cr and Rs 75.42 Cr.
  • 10. Is Albert David giving dividend?
    Albert David Ltd. announced an equity dividend of 115% on a face value of 10.0 amounting to Rs 11.5 per share on 13 May 2024. The ex dividend date was 02 Aug 2024.
  • 11. Who's the owner of Albert David?
      • Promoter holding has not changed in last 9 months and holds 62.13 stake as on 31 Dec 2024
      • Domestic Institutional Investors holding have gone down from 1.66 (31 Mar 2024) to 1.62 (31 Dec 2024)
      • Foreign Institutional Investors holding have gone down from 0.98 (31 Mar 2024) to 0.86 (31 Dec 2024)
      • Other investor holding has gone up from 35.23 (31 Mar 2024) to 35.39 (31 Dec 2024)
  • 12. Which are the key peers to Albert David?
    Within Pharmaceuticals sector Albert David, Medicamen Biotech Ltd., Medico Remedies Ltd., Ind-Swift Laboratories Ltd., Wanbury Ltd., Nectar Lifesciences Ltd., Zim Laboratories Ltd., Kilitch Drugs(I) Ltd., Lyka Labs Ltd., Kopran Ltd. and Venus Remedies Ltd. are usually compared together by investors for analysis.

Top Gainers

As on 11:32 AM | 04 Mar 2025
Jyoti CNC Automation
866.50
95.75 (12.43%)
Vijaya Diagnostic
1,029.20
96.56 (10.36%)
India Cements
279.60
23.06 (8.99%)
Concord Biotech Ltd.
1,643.70
122.30 (8.04%)
Alok Industries
16.05
1.17 (7.87%)

Top Losers

As on 11:34 AM | 04 Mar 2025
Astral Poly Tech
1,306.20
-42.15 (-3.13%)
Balkrishna Ind.
2,502.00
-80.50 (-3.12%)
Bajaj Auto
7,480.00
-234.81 (-3.05%)
LTIMindtree
4,692.25
-141.95 (-2.94%)
Adani Green
780.50
-23.61 (-2.94%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.